| Literature DB >> 21632825 |
Soona Shin1, Gabriel Walton, Reina Aoki, Karrie Brondell, Jonathan Schug, Alan Fox, Olga Smirnova, Craig Dorrell, Laura Erker, Andrew S Chu, Rebecca G Wells, Markus Grompe, Linda E Greenbaum, Klaus H Kaestner.
Abstract
Isolation of hepatic progenitor cells is a promising approach for cell replacement therapy of chronic liver disease. The winged helix transcription factor Foxl1 is a marker for progenitor cells and their descendants in the mouse liver in vivo. Here, we purify progenitor cells from Foxl1-Cre; RosaYFP mice and evaluate their proliferative and differentiation potential in vitro. Treatment of Foxl1-Cre; RosaYFP mice with a 3,5-diethoxycarbonyl-1,4-dihydrocollidine diet led to an increase of the percentage of YFP-labeled Foxl1(+) cells. Clonogenic assays demonstrated that up to 3.6% of Foxl1(+) cells had proliferative potential. Foxl1(+) cells differentiated into cholangiocytes and hepatocytes in vitro, depending on the culture condition employed. Microarray analyses indicated that Foxl1(+) cells express stem cell markers such as Prom1 as well as differentiation markers such as Ck19 and Hnf4a. Thus, the Foxl1-Cre; RosaYFP model allows for easy isolation of adult hepatic progenitor cells that can be expanded and differentiated in culture.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21632825 PMCID: PMC3110956 DOI: 10.1101/gad.2027811
Source DB: PubMed Journal: Genes Dev ISSN: 0890-9369 Impact factor: 11.361